Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy

Cook, D. P., Wu, A. Y., Thomas, C. M., Hamilton, R. G., Stokes Peebles, R., & Kerchberger, V. E. (2024, December 1). Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy. Allergy: European Journal of Allergy and Clinical Immunology. John Wiley and Sons Inc. https://doi.org/10.1111/all.16198